Approximately 40-50% of SLE patients are positive for anti-TRIM21 antibodies, frequently combined with anti-Ro60 and anti-La antibodies; the occurrence of anti-TRIM21 antibody positivity by itself is uncommon in SLE, Table 3 (141, 146, 147). The gene discussed is TRIM21; the disease is systemic lupus erythematosus.